Prebiotic xylooligosaccharides ameliorate metabolic dysfunction-associated steatotic liver disease via modulating gut microbiota and metabolites

Abstract The study investigated the dose-dependent protective effects of xylooligosaccharides (XOS) against metabolic dysfunction-associated steatotic liver disease (MASLD) in mice, focusing on gut microbiota and microbial metabolites. Male C57BL/6 mice were fed either a low-fat diet(LFD), a high-fa...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Li Chen, Ti-Dong Shan
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Nature Portfolio 2026-04-01
Edice:	Scientific Reports
Témata:	MASLD XOS gut microbiota metabolomics dose response
On-line přístup:	https://doi.org/10.1038/s41598-026-48643-8
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!